Cosopt Pf Solution/ Drops
Product Images NDC 82584-604

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cosopt Pf (NDC 82584-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Thea Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cosopt 01)

FDA Label Image

Chemical Structure (Cosopt 02)

FDA Label Image

Figure A (Cosopt 03)

FDA Label Image

Figure B (Cosopt 04)

FDA Label Image

Figure C (Cosopt 05)

FDA Label Image

Figure D (Cosopt 06)

FDA Label Image

Principal Display Panel (0.2 mL Vial Pouch Carton)

Principal Display Panel (0.2 mL Vial Pouch Carton)
This is a description of medication called COSOPT PF, a sterile preservative-free solution containing dorzolamide HCl and timolol maleate for topical application in the eye. It is available in a pack of 60 Single-use Containers. The solution is to be stored between 20° to 25°C and should not be frozen. The usual dosage is one drop in the morning and one drop in the evening in the affected eye(s). After the pouch is opened, the remaining single-use containers should be stored in the foil pouch to protect them from light. Unopened containers should be thrown away 15 days after the pouch is opened. The eye drops should be used immediately after use, and any remaining solution should be discarded.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.